Abeona Therapeutics(ABEO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABEO Abeona Therapeutics

Closed Good Friday 04-17 16:00:00 EDT

4.84

-0.01

-0.21%

盘后4.84

+0.000.00%

17:31 EDT

High4.96	Low4.82	Vol822.76K
Open4.87	D1 Closing4.85	Amplitude2.89%
Mkt Cap234.90M	Tradable Cap165.53M	Total Shares48.53M
T/O4.00M	T/O Rate2.41%	Tradable Shares34.20M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ABEO","market":"US","secType":"STK","nameCN":"Abeona Therapeutics","latestPrice":4.84,"timestamp":1744920000000,"preClose":4.85,"halted":0,"volume":822763,"hourTrading":{"tag":"盘后","latestPrice":4.84,"preClose":4.84,"latestTime":"17:31 EDT","volume":19634,"amount":95037.0088,"timestamp":1744925483229},"delay":0,"floatShares":34200068,"shares":48533798,"eps":-1.552662,"marketStatus":"Closed Good Friday","change":-0.01,"latestTime":"04-17 16:00:00 EDT","open":4.87,"high":4.955,"low":4.815,"amount":4000905.3411551,"amplitude":0.028866,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.552662,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.85,"postHourTrading":{"tag":"盘后","latestPrice":4.84,"preClose":4.84,"latestTime":"17:31 EDT","volume":19634,"amount":95037.0088,"timestamp":1744925483229},"volumeRatio":0.8864602830377339,"impliedVol":1.9158,"impliedVolPercentile":0.6574},"requestUrl":"/m/hq/s/ABEO","defaultTab":"news","newsList":[{"id":"2525867062","title":"Abeona Therapeutics Inc : Stifel Resumes Coverage With Buy Rating; Target Price $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2525867062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525867062?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 18:46","pubTimestamp":1744109173,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1A7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABEO"],"gpt_icon":0},{"id":"2524297226","title":"Abeona Therapeutics Rises in Volume Spike, Last up 5.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524297226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524297226?lang=en_us&edition=full_marsco","pubTime":"2025-04-04 03:18","pubTimestamp":1743707895,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250403:nL2N3QH144:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABEO"],"gpt_icon":0},{"id":"2524115697","title":"Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524115697","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524115697?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 19:30","pubTimestamp":1743507000,"startTime":"0","endTime":"0","summary":"CLEVELAND, April 01, 2025  -- Abeona Therapeutics Inc.  today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635.On March 31, 2025, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to six individuals hired by Abeona, which equity awards relate to, in the aggregate, up to 23,700 restricted shares of Abeona common stock. One-third of the shares subject to such restricted stock awards will vest yearly on each anniversary of the Grant Date, such that the shares subject to such restricted stock awards granted to each employee will be fully vested on the third anniversary of the Grant Date, in each case, subject to each employee’s continued employment with Abeona on the applicable vesting dates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abeona-therapeutics-announces-employee-inducement-113000084.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","ABEO","BK4139","USJW.SI","IE00BKPKM429.USD","NVIW.SI","NDAQ","MNQmain",".IXIC","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","BK4112","IE00B3QW5Z07.USD","QLD","USAW.SI","IE00BGHQF748.EUR","PSQ","LU2210150020.SGD","LU2095319765.USD","QID","SQQQ","BK4585","BK4588","TQQQ"],"gpt_icon":1},{"id":"2522706599","title":"ABEO: Countdown to PDUFA Date of April 29, 2025…","url":"https://stock-news.laohu8.com/highlight/detail?id=2522706599","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522706599?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 22:04","pubTimestamp":1742825040,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics, Inc.  is continuing preparations for the potential commercial launch of prademagene zamikeracel , which has a PDUFA target action date of April 29, 2025. The company resubmitted the Biologics License Application  following receipt of a Complete Response Letter  in 2024 in which the FDA identified the need for additional Chemistry, Manufacturing and Controls  data pertaining to the validation of certain manufacturing and release testing methods. Abeona aligned with the FDA on the content necessary for resubmission of the BLA and is confident that it met all of the agency’s requests. In the CRL, the FDA did not identify any deficiencies related to the clinical efficacy or clinical safety data, there were no requests for additional clinical data or any new clinical trials, and the FDA does not plan on conducting an Advisory Committee meeting regarding the BLA.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abeo-countdown-pdufa-date-april-140400772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4530","BK4006","LU1363072403.SGD","BK4139","IE00BKVL7J92.USD","CMC","ABEO","LU0267386448.USD","BK4585","BK4588","IE00BZ1G4Q59.USD","IE00B1BXHZ80.USD","LU0170899867.USD","BK4121","CRL","IE00BHPRN162.USD","LU0149725797.USD","LU0971096721.USD","LU0882574139.USD","LU0390134368.USD"],"gpt_icon":0},{"id":"2521243746","title":"Abeona Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2521243746","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521243746?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 19:09","pubTimestamp":1742814540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 24, 2025 07:09 ET (11:09 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO"],"gpt_icon":0},{"id":"2521264915","title":"Abeona Therapeutics: Positive Outlook Amid FDA Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2521264915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521264915?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 08:21","pubTimestamp":1742602891,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc (($ABEO)) has held its Q4 earnings call. Read on for the main highlights of the call. Abeona Therapeutics Inc. recently hel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abeona-therapeutics-positive-outlook-amid-fda-hopes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abeona-therapeutics-positive-outlook-amid-fda-hopes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABEO"],"gpt_icon":0},{"id":"2521425707","title":"Q4 2024 Abeona Therapeutics Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2521425707","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521425707?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 12:41","pubTimestamp":1742532100,"startTime":"0","endTime":"0","summary":"Greg Gin; Vice President, Investor Relations and Corporate Communications; Abeona Therapeutics Inc. Vishwas Seshadri; President, Chief Executive Officer, Director; Abeona Therapeutics Inc. Madhav Vasanthavada; Chief Commercial Officer, Head of Business Development; Abeona Therapeutics Inc. Brian Kevany; Senior Vice President, Chief Technical Officer & Chief Scientific Officer; Abeona Therapeutics Inc. Joseph Vazzano; Chief Financial Officer; Abeona Therapeutics Inc. Thank you, Greg. We appreciate everybody joining the call this morning. We're less than six weeks away from our PDUFA date of April 29 for prademagene zamikeracel, or pz-cel for receptive dystrophic epidermolysis bullosa or RDEB. Since resubmitting our pz-cel biologics license application in late October and receiving FDA acceptance in early November, we have been working with the FDA on the review process.As a reminder, the FDA has not indicated the need for additional site inspections or an outcome as part of this review.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-abeona-therapeutics-inc-044140247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABEO"],"gpt_icon":0},{"id":"2521462618","title":"Abeona price target raised to $25 from $20 at Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2521462618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521462618?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 01:11","pubTimestamp":1742490664,"startTime":"0","endTime":"0","summary":"Alliance Global Partners raised the firm’s price target on Abeona Therapeutics (ABEO) to $25 from $20 and keeps a Buy rating on the shares after th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-price-target-raised-to-25-from-20-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-price-target-raised-to-25-from-20-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"2520560524","title":"Abeona Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2520560524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520560524?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 20:45","pubTimestamp":1742474704,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryAbeona Therapeutics Inc ABEO.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nL8N3Q317O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO"],"gpt_icon":0},{"id":"2520610458","title":"Abeona Therapeutics 2024 EPS $(1.55) Up From $(2.53) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2520610458","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520610458?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:36","pubTimestamp":1742470592,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics 2024 EPS $(1.55) Up From $(2.53) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44413855/abeona-therapeutics-2024-eps-1-55-up-from-2-53-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Abeona Therapeutics 2024 EPS $(1.55) Up From $(2.53) YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO"],"gpt_icon":0},{"id":"2520245893","title":"Abeona Therapeutics reports FY24 EPS ($1.55) vs ($2.53) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2520245893","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520245893?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:36","pubTimestamp":1742470587,"startTime":"0","endTime":"0","summary":"“The RDEB community continues to highlight the unmet medical need for new therapies that could provide long-lasting healing and pain reduction, eve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-reports-fy24-eps-1-55-vs-2-53-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-reports-fy24-eps-1-55-vs-2-53-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABEO"],"gpt_icon":0},{"id":"2520588734","title":"Abeona Therapeutics Inc - Pz-Cel Launch Preparations on Track for 3Q 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520588734","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520588734?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:30","pubTimestamp":1742470201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA5L0YQC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABEO"],"gpt_icon":0},{"id":"2520458823","title":"Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-Cel Regulatory Update and Commercial Launch Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2520458823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520458823?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:30","pubTimestamp":1742470201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA5L0YQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"2520807458","title":"Abeona Therapeutics FY EPS USD -1.55 VS. Ibes Estimate USD -1.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2520807458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520807458?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:30","pubTimestamp":1742470200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nPLX0D894C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"2520583614","title":"Press Release: Abeona Therapeutics(R) Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2520583614","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520583614?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:30","pubTimestamp":1742470200,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans. FDA priority review of pz-cel Biologics License Application  progressing with Prescription Drug User Fee Act  target action date of April 29, 2025. Launch preparations on track toward goal to treat first patient in 3Q 2025. CLEVELAND, March 20, 2025  -- Abeona Therapeutics Inc.  today reported financial results for the full year of 2024, and announced progress in the ongoing review with the U.S. Food and Drug Administration  regarding prademagene zamikeracel  and plans for the U.S. commercial launch of pz-cel for recessive dystrophic epidermolysis bullosa , if approved. The Company will host a conference call and webcast today at 8:30 a.m. ET.\"The RDEB community continues to highlight the unmet medical need for new therapies that could provide long-lasting healing and pain reduction, even in tough large, chronic RDEB wounds,\" said Vish Seshadri, Chief Executive O","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4022","TM","03160","BK4139","ABEO","BK4099","BK4604","BK4232","BK4555","BK4588","R"],"gpt_icon":0},{"id":"2519680146","title":"Abeona Therapeutics Inc  expected to post a loss of 35 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519680146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519680146?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 21:08","pubTimestamp":1741957685,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics Inc  expected to post a loss of35cents a share - Earnings Preview Abeona Therapeutics Inc ABEO.OQ ABEO.O is expected to show a rise in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX17N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO"],"gpt_icon":0},{"id":"2517369917","title":"Abeona Therapeutics Initiated at Outperform by Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2517369917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517369917?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 22:05","pubTimestamp":1741183500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 05, 2025 09:05 ET (14:05 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","OPY"],"gpt_icon":0},{"id":"2516674882","title":"Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516674882","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516674882?lang=en_us&edition=full_marsco","pubTime":"2025-03-04 22:00","pubTimestamp":1741096800,"startTime":"0","endTime":"0","summary":"CLEVELAND, March  04, 2025  (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., will present at the Leerink","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036603/0/en/Abeona-Therapeutics-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABEO","HCSG","BK4137","BK4139"],"gpt_icon":0},{"id":"2516638027","title":"Abeona Therapeutics announces new employee inducement grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2516638027","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516638027?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:46","pubTimestamp":1741005967,"startTime":"0","endTime":"0","summary":"Abeona Therapeutics (ABEO) has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in acco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-announces-new-employee-inducement-grants-9?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abeona-therapeutics-announces-new-employee-inducement-grants-9?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABEO","BK4139"],"gpt_icon":0},{"id":"2516568000","title":"Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516568000","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516568000?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 20:30","pubTimestamp":1741005002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA8PK6XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ABEO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abeonatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1579},{"period":"1month","weight":-0.062},{"period":"3month","weight":-0.0728},{"period":"6month","weight":-0.2744},{"period":"1year","weight":-0.3897},{"period":"ytd","weight":-0.1311}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.1,"avgChangeRate":-0.109902},{"month":2,"riseRate":0.6,"avgChangeRate":0.122147},{"month":3,"riseRate":0.6,"avgChangeRate":0.002349},{"month":4,"riseRate":0.7,"avgChangeRate":-0.01384},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.006254},{"month":6,"riseRate":0.333333,"avgChangeRate":0.013485},{"month":7,"riseRate":0.4,"avgChangeRate":-0.02946},{"month":8,"riseRate":0.6,"avgChangeRate":0.073418},{"month":9,"riseRate":0.4,"avgChangeRate":0.011715},{"month":10,"riseRate":0.6,"avgChangeRate":0.004607},{"month":11,"riseRate":0.4,"avgChangeRate":0.090546},{"month":12,"riseRate":0.1,"avgChangeRate":-0.155135}],"exchange":"NASDAQ","name":"Abeona Therapeutics","nameEN":"Abeona Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abeona Therapeutics(ABEO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Abeona Therapeutics(ABEO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Abeona Therapeutics,ABEO,Abeona Therapeutics股票,Abeona Therapeutics股票老虎,Abeona Therapeutics股票老虎国际,Abeona Therapeutics行情,Abeona Therapeutics股票行情,Abeona Therapeutics股价,Abeona Therapeutics股市,Abeona Therapeutics股票价格,Abeona Therapeutics股票交易,Abeona Therapeutics股票购买,Abeona Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abeona Therapeutics(ABEO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Abeona Therapeutics(ABEO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}